Systolic Pressure Index in Assessing the Risk of Cardiovascular Events (IPS)
To investigate whether the presence of a Systolic pressure index (<0.9 or> 1.4) is a marker of risk of cardiovascular events after peri-operative high-risk surgery outside the cardiac and vascular surgery.
|Study Design:||Time Perspective: Prospective|
|Official Title:||Interest of Measuring the Systolic Pressure Index in Assessing the Risk of Cardiovascular Events Peri-operatively in the Surgery, Settled Out of Cardiovascular Surgery|
- It is a composite involving the following events: death, cardiovascular death, acute coronary syndrome, left cardiac decompensation, stroke, transient ischemic attack [ Time Frame: day1, day 2, day 3, 1 month, 1 year ] [ Designated as safety issue: No ]
- - for the short term increase in the length of hospitalization - for the long term: death, cardiovascular death, hospitalization for acute coronary syndrome, cardiac decompensation left, TIA, stroke, acute ischemia and ischemia critical member. [ Time Frame: day1, day 2, day 3, 1 month, 1 year ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Blood sample to evaluate Troponin, a Cardiac biomarker
|Study Start Date:||January 2008|
|Study Completion Date:||September 2009|
|Primary Completion Date:||August 2009 (Final data collection date for primary outcome measure)|
Patients with Systolic Pressure Index <0,9 ou >1,4.
Patients not exposed
Patients with Systolic Pressure Index >0,9 ou <1,4.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00925964
|Explorations fonctionnelles vasculaires et angiologie (Hôpital Dupuytren)|
|Limoges, France, 87000|
|Principal Investigator:||Philippe LACROIX, MD||University Hospital, Limoges|